Neoplasia/BPH

	Cost-effectiveness of PSMA-PET imaging technology in diagnosing and staging of prostate cancer: a systematic review. Ther Adv Urol Sanyal C, Rendon R. PMID: 41918916 [PubMed]
	Application of adaptive deep learning-based automatic segmentation in radiomics model for preoperative WHO/ISUP grading of clear cell renal cell carcinoma: a retrospective comparative study with manual segmentation. PeerJ Zhu H, Chen Z, Zhang J, Yang M, Gu K, Bao W, Du Y, Hou S, Yao W. PMID: 41918861 [PubMed - indexed for MEDLINE]
	Breast Cancer Metastasis to a Renal Cell Carcinoma: A Comprehensive Review with Emphasis on Novel Immunohistochemical Tools. Int J Surg Pathol Conde Ferreirós M, Abdulkader Sande S, Barreiro MNA, Bellas Pereira A, Ortiz Rey JA. PMID: 41918273 [PubMed - as supplied by publisher]
	Testis-sparing surgery for Leydig cell tumor in children: long-term results of a multicentric retrospective cohort study. BMC Urol Wei J, Li Z, Du G, Yang C, Li N, Yang M, Tang D. PMID: 41917881 [PubMed - as supplied by publisher]
	Multidisciplinary evaluation improves prevalence of testis-sparing surgery in children with testicular benign tumors: a cross-section study. BMC Cancer Guo B, Bai WJ, Liu ZH, Qin ZK, Ye YL. PMID: 41917860 [PubMed - as supplied by publisher]
	True Papillae and Squamous Features in Prostate Carcinoma Represent a Potential Diagnostic Pitfall: Report of 3 Patients. Int J Surg Pathol Grypari IM, Pomoni A, Ganetsou D, Kouroukli O, Melachrinou M, Tzelepi V. PMID: 41917793 [PubMed - as supplied by publisher]
	Robotic assisted versus non-robotic retroperitoneal lymph node dissection for testicular cancer: an updated systematic review and meta-analysis. J Robot Surg Rath S, Alam U, Kashif A, Khan AS, Ansab M, Burhan M, Siddiqui HT, Asif MA, Moiz A, Hanif H. PMID: 41917252 [PubMed - in process]
	Re: European Study of Prostate Cancer Screening - 23-Year Follow-up. Eur Urol Montironi R, Giannarini G, Cimadamore A, Lopez-Beltran A, Rogers ET, Cheng L. PMID: 41916801 [PubMed - as supplied by publisher]
	Strategies for prevention, early detection and management of penile and testicular cancer in primary healthcare: scoping review protocol. BMJ Open Sant'Ana RSE, de Matos WDV, Amaral JBDA, Calleja S, Maheu C, Hart NH, Rabelo AL, Sousa AR. PMID: 41916624 [PubMed - indexed for MEDLINE]
	BPI26-007: Avoiding Unnecessary Biopsies for Non-Clinically Significant Prostate Cancer in Patients With PSA 4-20 ng/mL Using PRIMARY Score â‰¤3 and PSAD â‰¤0.2 ng/mL/cmÂ³: A Real-World, Dual-Centre Study From China. J Natl Compr Canc Netw He J, Qi L, Chen M, Hu S, Gao X, Tang Y, Chen S, Cai Y. PMID: 41916360 [PubMed - in process]
	Optimizing the Systemic Treatment for Metastatic Castration-Resistant Prostate Cancer in Lower-Middle-Income Countries: A 7-Year Analysis of the Brazilian Public Health System. JCO Glob Oncol Monteiro FSM, Souza VC, da Trindade KM, E Silva AG, Mota A, Bastos DA, Valverde DA, Abboud HS, Herchenhorn D, Soares A. PMID: 41915874 [PubMed - indexed for MEDLINE]
	Proliferation associates with greater sensitivity to androgen receptor pathway inhibition for metastatic prostate cancer. J Clin Invest Mendes L, Dutey-Magni PF, Grist E, Sachdeva A, Santos Vidal S, Lall S, Parry MA, Amos CL, Atako NB, Wingate A, Wetterskog D, Sydes MR, Parker CC, Clarke N, Sweeney CJ, Parmar MK, Brown LC, James ND, Berney DM, Attard G. PMID: 41915426 [PubMed - as supplied by publisher]
	Emerging roles for the epigenetic modifiers PBRM1 SETD2 and BAP1 in clear cell renal cell carcinoma pathogenesis and prognosis beyond VHL. Discov Oncol Jixiang B, Xin C, Xiaoxuan P, Mingli S, Jieru H, Shuhui W. PMID: 41915349 [PubMed - as supplied by publisher]
	Testosterone-Sparing Treatment Strategies for Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Curr Oncol Rep Najdawi F, Sayyid RK, Ahlering T, Lee DI, Dobbs RW, Shahait M. PMID: 41915319 [PubMed - indexed for MEDLINE]
	The role of apoptotic genetic polymorphisms in prostate cancer susceptibility in a North West Spain population. Mol Genet Genomics López-Trigo N, Caeiro B, Pérez-Pérez J, Rodríguez-Alonso A, Aguín N, Rodríguez JA, Luis JR. PMID: 41915239 [PubMed - indexed for MEDLINE]
	[Early detection of prostate cancer-recommendations of the updated S3Â guideline 2025]. Urologie Al-Monajjed R, Albers P, Franiel T, Kötter T, Kristiansen G, Herrmann K, Wiegel T. PMID: 41915026 [PubMed - as supplied by publisher]
	Anti-Inflammatory Diet Index (AIDI) and Bladder Cancer Risk by Stage: A 22-Year Prospective Swedish Cohort Study (1998-2020). Cancer Epidemiol Biomarkers Prev Prado S, Ugge H, Vikerfors A, Fall K, Taj T. PMID: 41914981 [PubMed - as supplied by publisher]
	PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving (177)Lu-PSMA-617. Radiology Ghodsi A, Owens L, Demirci RA, Gafita A, Cheng HH, Hawley JE, Raychaudhuri R, Khan H, Sunkara R, Hsieh AC, Grivas P, Montgomery B, Yezefski TA, Nelson PS, Yu EY, Schweizer MT, Chen DL, Gulati R, Iravani A. PMID: 41914866 [PubMed - indexed for MEDLINE]
	PD-1/PD-L1 for prostate cancer: from clinical trials to practice. Expert Rev Clin Pharmacol Holmes A, Okobi T, Arham AB, Vaishampayan N, Subramanya D, Tagawa ST. PMID: 41914824 [PubMed - as supplied by publisher]
	Prognostic value of Ki67 and PSA-immunostaining in de novo metastatic hormone-sensitive prostate cancer. Arch Ital Urol Androl Ferreira AM, Jarimba R, Rego A, Gama J, Almeida R, Eliseu M, Quaresma V, Nunes P, Sousa V, Figueiredo A. PMID: 41914231 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 186727

Page 1 of 9337



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy